Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 4031671, 5 pages
https://doi.org/10.1155/2017/4031671
Research Article

The Distribution Frequency of Interferon-Gamma Receptor 1 Gene Polymorphisms in Interferon-γ Release Assay-Positive Patients

1Department of Clinical Laboratory, The Navy General Hospital, No. 6 Fucheng Road, Beijing 100037, China
2Department of Pathology, Donghua Hospital Affiliated to Zhongshan University, No. 1 Dongcheng Road, Dongguan, Guangdong 523110, China

Correspondence should be addressed to Changguo Chen

Received 11 September 2017; Revised 1 October 2017; Accepted 8 October 2017; Published 25 October 2017

Academic Editor: Marco E. M. Peluso

Copyright © 2017 Changguo Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Lin and J. L. Flynn, “Understanding latent tuberculosis: a moving target,” The Journal of Immunology, vol. 185, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kondratieva, T. Azhikina, B. Nikonenko, A. Kaprelyants, and A. Apt, “Latent tuberculosis infection: what we know about its genetic control?” Tuberculosis, vol. 94, no. 5, pp. 462–468, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Raviglione and G. Sulis, “Tuberculosis 2015: burden, challenges and strategy for control and elimination,” Infectious Disease Reports, vol. 8, no. 2, p. 6570, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Mjid, J. Cherif, N. Ben Salah et al., “Epidemiology of tuberculosis,” Revue de Pneumologie Clinique, vol. 71, no. 2-3, pp. 67–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Zumla, A. George, V. Sharma, N. Herbert, and Baroness Masham of Ilton, “WHO’s 2013 global report on tuberculosis: successes, threats, and opportunities,” The Lancet, vol. 382, no. 9907, pp. 1765–1767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. El Kamel, S. Joobeur, N. Skhiri, S. Cheikh Mhamed, H. Mribah, and N. Rouatbi, “Fight against tuberculosis in the world,” Revue de Pneumologie Clinique, vol. 71, no. 2-3, pp. 181–187, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Li, J. L. Wang, B. Y. Ji et al., “Persistently high prevalence of primary resistance and multidrug resistance of tuberculosis in Heilongjiang province, China,” BMC Infectious Diseases, vol. 16, no. 1, p. 516, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Xu, T. Xiao, Y. Li, K. Yang, Y. Tang, and L. Bai, “Reasons for non-enrollment in treatment among multi-drug resistant tuberculosis patients in Hunan province, China,” PLoS One, vol. 12, no. 1, article e0170718, 2017. View at Publisher · View at Google Scholar
  9. P. Glaziou, D. Falzon, K. Floyd, and M. Raviglione, “Global epidemiology of tuberculosis,” Seminars in Respiratory and Critical Care Medicine, vol. 34, no. 1, pp. 3–16, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Yang, Y. Yuan, Y. Pang et al., “The burden of MDR/XDR tuberculosis in coastal plains population of China,” PLoS One, vol. 10, no. 2, article e0117361, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zhang, X. Li, H. Xin et al., “Association of body mass index with the tuberculosis infection: a population-based study among 17796 adults in rural China,” Scientific Reports, vol. 7, article 41933, 2017. View at Publisher · View at Google Scholar
  12. M. H. Haverkamp, J. T. van Dissel, and S. M. Holland, “Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-γ-dependent signaling,” Microbes and Infection, vol. 8, no. 4, pp. 1157–1166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Q. Qu, S. P. Fisher-Hoch, and J. B. McCormick, “Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases,” International Journal of Infectious Diseases, vol. 15, no. 5, pp. e305–e313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Nienhaus, A. Schablon, J. T. Costa, and R. Diel, “Systematic review of cost and cost-effectiveness of different TB-screening strategies,” BMC Health Services Research, vol. 11, p. 247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. L. de Souza-Galvao, I. Latorre, N. Altet-Gomez et al., “Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis,” BMC Infectious Diseases, vol. 14, no. 1, p. 258, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Diel, D. Goletti, G. Ferrara et al., “Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis,” The European Respiratory Journal, vol. 37, no. 1, pp. 88–99, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Diel, R. Loddenkemper, and A. Nienhaus, “Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state,” Chest, vol. 142, no. 1, pp. 63–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Chen, L. Guo, M. Shi et al., “Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells,” The American Journal of Pathology, vol. 180, no. 2, pp. 661–671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. C. M. Ahmed and H. M. Johnson, “IFN-γ and its receptor subunit IFNGR1 are recruited to the IFN-γ-activated sequence element at the promoter site of IFN-γ-activated genes: evidence of transactivational activity in IFNGR1,” The Journal of Immunology, vol. 177, no. 1, pp. 315–321, 2006. View at Publisher · View at Google Scholar
  20. G. S. Cooke, S. J. Campbell, J. Sillah et al., “Polymorphism within the interferon-γ/receptor complex is associated with pulmonary tuberculosis,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 3, pp. 339–343, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lü, H. Pan, Y. Chen et al., “Genetic polymorphisms of IFNG and IFNGR1 in association with the risk of pulmonary tuberculosis,” Gene, vol. 543, no. 1, pp. 140–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Hashemi, E. Eskandari-Nasab, A. Moazeni-Roodi, M. Naderi, B. Sharifi-Mood, and M. Taheri, “Association of CTSZ rs34069356 and MC3R rs6127698 gene polymorphisms with pulmonary tuberculosis,” The International Journal of Tuberculosis and Lung Disease, vol. 17, no. 9, pp. 1224–1228, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Onozaki and M. Raviglione, “Stopping tuberculosis in the 21st century: goals and strategies,” Respirology, vol. 15, no. 1, pp. 32–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. D. van Helden, M. Möller, C. Babb et al., “TB epidemiology and human genetics,” Novartis Foundation Symposia, vol. 279, pp. 17–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Aggelou, E. K. Siapati, I. Gerogianni et al., “The -938C>A polymorphism in MYD88 is associated with susceptibility to tuberculosis: a pilot study,” Disease Markers, vol. 2016, Article ID 4961086, 5 pages, 2016. View at Publisher · View at Google Scholar
  26. E. Ghamari, P. Farnia, S. Saif et al., “Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2),” International Journal of Mycobacteriology, vol. 5, Supplement 1, pp. S136–S137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Caceres, N. Rastogi, C. Bartra et al., “Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru,” PLoS One, vol. 9, no. 12, article e112789, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Catherinot, C. Fieschi, J. Feinberg, J. L. Casanova, and L. J. Couderc, “Genetic susceptibility to mycobacterial disease: Mendelian disorders of the interleukin-12 – interferon-axis,” Revue des Maladies Respiratoires, vol. 22, 5, Part 1, pp. 767–776, 2005. View at Publisher · View at Google Scholar
  29. P. Farnia, J. Ghanavi, P. Tabasri, S. Saif, and A. A. Velayati, “The importance of single nucleotide polymorphisms in interferon gamma receptor-1 gene in pulmonary patients infected with rapid grower mycobacterium,” International Journal of Mycobacteriology, vol. 5, Supplement 1, pp. S210–S211, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. W. T. Quispel, J. A. Stegehuis-Kamp, S. J. Santos et al., “Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from Mendelian susceptibility to mycobacterial disease,” Journal of Clinical Immunology, vol. 34, no. 1, pp. 84–93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Sologuren, S. Boisson-Dupuis, J. Pestano et al., “Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds,” Human Molecular Genetics, vol. 20, no. 8, pp. 1509–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Remiszewski, B. Roszkowska-Sliz, J. Winek et al., “Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNγR1 deficiency,” Respiration, vol. 73, no. 3, pp. 375–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. J. G. Shin, B. L. Park, L. H. Kim et al., “Association study of polymorphisms in interferon-γ receptor genes with the risk of pulmonary tuberculosis,” Molecular Medicine Reports, vol. 12, no. 1, pp. 1568–1578, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Velayati, P. Farnia, S. Khalizadeh, A. M. Farahbod, M. Hasanzadh, and M. F. Sheikolslam, “Interferon-gamma receptor-1 gene promoter polymorphisms and susceptibility to leprosy in children of a single family,” The American Journal of Tropical Medicine and Hygiene, vol. 84, no. 4, pp. 627–629, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Farnia, J. Ghanavi, S. Saif, P. Farnia, and A. A. Velayati, “Association of interferon-γ receptor-1 gene polymorphism with nontuberculous mycobacterial lung infection among Iranian patients with pulmonary disease,” The American Journal of Tropical Medicine and Hygiene, vol. 97, no. 1, pp. 57–61, 2017. View at Publisher · View at Google Scholar
  36. L. Bulat-Kardum, G. E. Etokebe, J. Knezevic et al., “Interferon-γ receptor-1 gene promoter polymorphisms (G-611A; T-56C) and susceptibility to tuberculosis,” Scandinavian Journal of Immunology, vol. 63, no. 2, pp. 142–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. D. Rosenzweig, A. A. Schaffer, L. Ding et al., “Interferon-γ receptor 1 promoter polymorphisms: population distribution and functional implications,” Clinical Immunology, vol. 112, no. 1, pp. 113–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Wang, W. Ren, X. Zhang, Y. Liu, and C. Li, “Association between interferon gamma receptor 1-56C/T gene polymorphism and tuberculosis susceptibility: a meta-analysis,” Chinese Medical Journal, vol. 127, no. 21, pp. 3782–3788, 2014. View at Google Scholar